Details of the Drug Formulaction

General Information of Drug Formulation (ID: F01373)

• Formulation Name: Aprepitant 125 mg capsule
• Company: Glenmark Pharmaceutials

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Aprepitant	(DM053KT)	Depression	6A70-6A7Z	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
FD&C red no. 3	(E00629)	Not Available	Colorant
Ferrosoferric oxide	(E00231)	14789	Colorant
Mannitol	(E00103)	6251	Diluent; Flavoring agent; Lyophilization aid; Plasticizing agent; Tonicity agent
Poloxamer 407	(E00646)	Not Available	Emulsifying agent; Solubilizing agent; Surfactant
Potassium hydroxide	(E00233)	14797	Alkalizing agent
Silicon dioxide	(E00670)	Not Available	Anticaking agent; Opacifying agent; Viscosity-controlling agent
Sodium lauryl sulfate	(E00464)	3423265	Emulsifying agent; Modified-release agent; Penetration agent; Solubilizing agent; Surfactant; lubricant
Sodium stearyl fumarate	(E00545)	23665634	lubricant
Titanium dioxide	(E00322)	26042	Coating agent; Colorant; Opacifying agent
Tocophersolan	(E00679)	Not Available	Antioxidant; Binding agent; Emulsifying agent; Ointment base; Solubilizing agent; Surfactant; Suspending agent
Water	(E00035)	962	Solvent